• Media Centre
  • Investor relations
  • Client area
  • Client area
  • Stewardship policy
  • Annual reports service

Form of Proxy

CLINUVEL PHARMACEUTICALS LTD

Notes

No. Proposition For Against Abstain
1

ADOPTION OF REMUNERATION REPORT (NON-BINDING RESOLUTION) THAT, IN ACCORDANCE WITH SECTION 250R OF THE CORPORATIONS ACT, THE REMUNERATION REPORT AS SET OUT IN THE DIRECTORS REPORT FOR THE YEAR ENDED 30 JUNE 2025, BE ADOPTED

2

RE-ELECTION OF PROFESSOR JEFFREY ROSENFELD THAT PROFESSOR JEFFREY ROSENFELD, A DIRECTOR RETIRING BY ROTATION IN ACCORDANCE WITH CLAUSE 57 OF THE CONSTITUTION OF THE COMPANY AND THE ASX LISTING RULES, BEING ELIGIBLE AND HAVING OFFERED HIMSELF FOR RE-ELECTION, BE RE-ELECTED AS A DIRECTOR

3

RE-ELECTION OF MR MATTHEW PRINGLE THAT MR MATTHEW PRINGLE, A DIRECTOR RETIRING BY ROTATION IN ACCORDANCE WITH CLAUSE 57 OF THE CONSTITUTION OF THE COMPANY AND THE ASX LISTING RULES, BEING ELIGIBLE AND HAVING OFFERED HIMSELF FOR RE-ELECTION, BE RE-ELECTED AS A DIRECTOR